Related Experiment Videos
Extended spectrum beta-lactamases: a therapeutic dilemma
1Department of Medicine (Infectious Diseases), University of Texas Health Science Center, San Antonio, TX, USA.
The Pediatric Infectious Disease Journal
|October 24, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
SHEA/APIC/IDSA/PIDS multisociety position paper: Raising the bar: necessary resources and structure for effective healthcare facility infection prevention and control programs.
Infection control and hospital epidemiology·2025
Essential Oils Can Mitigate Adverse Effects of Prolonged Masking in the Hospital Setting.
Holistic nursing practice·2022
The Clinical Safety and Effectiveness Course: Ten Years of Experiential Training in Quality Improvement for Practicing Professionals.
American journal of medical quality : the official journal of the American College of Medical Quality·2021
Timing of Loss of Transplacental Antibodies in Infants Born to Mothers Living With Human T-cell Lymphotropic Virus Type 1.
The Pediatric infectious disease journal·2026
Optimizing Posaconazole Suspension Prophylaxis in Pediatric Patients: The Key Role of Therapeutic Drug Monitoring.
The Pediatric infectious disease journal·2026
Long-term Cardiovascular and Psychological Outcomes of Multisystem Inflammatory Syndrome in Children: A Prospective Observational Study (COPE MIS-C study).
The Pediatric infectious disease journal·2026
Changes in Pediatric Tetracycline Prescribing Patterns During the 2024 Mycoplasma pneumoniae Pneumonia Epidemic in the Republic of Korea.
The Pediatric infectious disease journal·2026
Tetanus in Children: Clinical Insights and Management From a Multicenter Study in Turkey.
The Pediatric infectious disease journal·2026
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026